• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于照料非卧床型无义突变杜氏肌营养不良症患者影响的定性研究。

A qualitative study on the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy.

作者信息

Williams Kate, Davidson Ian, Rance Mark, Buesch Katharina, Acaster Sarah

机构信息

Acaster Lloyd Consulting Ltd, 16 Upper Woburn Place, London, WC1H 0BS, UK.

PTC Therapeutics Ltd, Building 2, Ground Floor, Guildford Business Park, Guildford, UK.

出版信息

J Patient Rep Outcomes. 2021 Aug 10;5(1):71. doi: 10.1186/s41687-021-00344-8.

DOI:10.1186/s41687-021-00344-8
PMID:34374872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8353428/
Abstract

BACKGROUND

Duchenne muscular dystrophy is a rare genetic neuromuscular disorder, which can result in early death due to disease progression. Ataluren is indicated for the treatment of nonsense mutation Duchenne muscular dystrophy, in ambulatory individuals aged two years and older. This study explored the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy, as well as the impact of treatment with ataluren on the caregiver experience, using retrospective recall.

METHODS

Qualitative interviews were conducted with caregivers in the UK. Interviews were conducted by telephone, were recorded and transcribed. Data were analysed using thematic analysis and saturation was recorded.

RESULTS

Ten interviews were conducted with parents of individuals aged 4-19 years. Caregivers reported proximal impacts (physical, emotional, time-related), and distal impacts (work, relationships, social life) of caring for their sons. The relationships between these impacts were illustrated in a conceptual model. Changes to the caregiver experience since initiation with their son's treatment were discussed.

CONCLUSION

Caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy has a substantial multifaceted impact on caregivers. Treatments which have the potential to improve symptoms or delay progression, may also have a positive impact on the quality of life of caregivers.

摘要

背景

杜氏肌营养不良症是一种罕见的遗传性神经肌肉疾病,疾病进展可能导致早期死亡。阿他芦醇适用于治疗年龄在两岁及以上、能行走的无义突变型杜氏肌营养不良症患者。本研究采用回顾性回忆法,探讨了照顾能行走的无义突变型杜氏肌营养不良症患者的影响,以及使用阿他芦醇治疗对照顾者体验的影响。

方法

对英国的照顾者进行了定性访谈。访谈通过电话进行,进行了录音和转录。使用主题分析法对数据进行分析,并记录了饱和度。

结果

对4至19岁患者的父母进行了10次访谈。照顾者报告了照顾儿子的近期影响(身体、情感、时间方面)和远期影响(工作、人际关系、社会生活)。这些影响之间的关系在一个概念模型中得到了说明。讨论了自儿子开始治疗以来照顾者体验的变化。

结论

照顾能行走的无义突变型杜氏肌营养不良症患者对照顾者有多方面的重大影响。有可能改善症状或延缓疾病进展的治疗方法,也可能对照顾者的生活质量产生积极影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc5/8355285/237d735c0f1d/41687_2021_344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc5/8355285/237d735c0f1d/41687_2021_344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc5/8355285/237d735c0f1d/41687_2021_344_Fig1_HTML.jpg

相似文献

1
A qualitative study on the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy.一项关于照料非卧床型无义突变杜氏肌营养不良症患者影响的定性研究。
J Patient Rep Outcomes. 2021 Aug 10;5(1):71. doi: 10.1186/s41687-021-00344-8.
2
Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model.门诊无义突变型杜氏肌营养不良症的症状与影响:一项定性研究及以患者为中心的概念模型的构建
J Patient Rep Outcomes. 2021 Aug 21;5(1):75. doi: 10.1186/s41687-021-00341-x.
3
The role of ataluren in the treatment of ambulatory and non-ambulatory children with nonsense mutation duchenne muscular dystrophy - a consensus derived using a modified Delphi methodology in Eastern Europe, Greece, Israel and Sweden.采用改良 Delphi 法在东欧、希腊、以色列和瑞典就非卧床和卧床杜氏肌营养不良症无义突变患儿使用氨苯砜治疗的共识。
BMC Neurol. 2024 Feb 21;24(1):73. doi: 10.1186/s12883-024-03570-x.
4
Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study.依替膦酸治疗杜氏肌营养不良症:一项定性患者体验研究。
Adv Ther. 2024 Aug;41(8):3278-3298. doi: 10.1007/s12325-024-02915-9. Epub 2024 Jul 3.
5
Assessment of face validity of a disease model of nonsense mutation Duchenne muscular dystrophy: a multi-national Delphi panel study.评估无义突变杜氏肌营养不良症疾病模型的表面有效性:一项多国家德尔菲小组研究。
J Med Econ. 2022 Jan-Dec;25(1):808-816. doi: 10.1080/13696998.2022.2085444.
6
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.依特醇治疗无义突变型杜氏肌营养不良症(ACT DMD)患者的疗效:一项多中心、随机、双盲、安慰剂对照的 3 期临床试验。
Lancet. 2017 Sep 23;390(10101):1489-1498. doi: 10.1016/S0140-6736(17)31611-2. Epub 2017 Jul 17.
7
A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective.一项从家长/患者角度理解杜氏肌营养不良症体验的定性研究。
J Patient Rep Outcomes. 2023 Dec 12;7(1):129. doi: 10.1186/s41687-023-00669-6.
8
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients.依伐布雷定改善射血分数降低心衰患者运动耐量及生活质量
J Comp Eff Res. 2022 Feb;11(3):139-155. doi: 10.2217/cer-2021-0196. Epub 2021 Nov 18.
9
Off-Label Use of Ataluren in Four Non-ambulatory Patients With Nonsense Mutation Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength.阿他芦仑在四名非卧床无义突变型杜氏肌营养不良患者中的超说明书用药:对心脏和肺功能及肌肉力量的影响
Front Pediatr. 2018 Oct 23;6:316. doi: 10.3389/fped.2018.00316. eCollection 2018.
10
Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy.对无义突变型杜氏肌营养不良症中阿托伦随机对照试验的荟萃分析。
J Comp Eff Res. 2020 Oct;9(14):973-984. doi: 10.2217/cer-2020-0095. Epub 2020 Aug 27.

引用本文的文献

1
Double burdened yet resilient: quality of life of caregivers of people with X-linked hypophosphatemia.负担双重却坚韧不拔:X连锁低磷血症患者照料者的生活质量
JBMR Plus. 2025 Apr 30;9(7):ziaf078. doi: 10.1093/jbmrpl/ziaf078. eCollection 2025 Jul.
2
Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study.依替膦酸治疗杜氏肌营养不良症:一项定性患者体验研究。
Adv Ther. 2024 Aug;41(8):3278-3298. doi: 10.1007/s12325-024-02915-9. Epub 2024 Jul 3.
3
Exploring the Dynamics of Caring for a Child With a Terminal Illness of Duchenne Muscular Dystrophy (DMD) and Its Copious Components on the Caregivers.

本文引用的文献

1
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.全球杜氏肌营养不良症的流行病学:一项更新的系统评价和荟萃分析。
Orphanet J Rare Dis. 2020 Jun 5;15(1):141. doi: 10.1186/s13023-020-01430-8.
2
Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review.描述与杜氏肌营养不良症相关的健康状态效用值:系统综述。
Qual Life Res. 2020 Mar;29(3):593-605. doi: 10.1007/s11136-019-02355-x. Epub 2019 Dec 6.
3
Duchenne muscular dystrophy and caregiver burden: a systematic review.
探索照顾患有杜氏肌营养不良症(DMD)绝症儿童的动态过程及其对照顾者的诸多影响因素。
Cureus. 2023 May 28;15(5):e39597. doi: 10.7759/cureus.39597. eCollection 2023 May.
4
Carer burden in rare inherited diseases: a literature review and conceptual model.罕见遗传性疾病照护者负担:文献回顾与概念模型。
Orphanet J Rare Dis. 2022 Dec 9;17(1):428. doi: 10.1186/s13023-022-02561-w.
5
Evaluating the Feasibility and Reliability of Remotely Delivering and Scoring the North Star Ambulatory Assessment in Ambulant Patients with Duchenne Muscular Dystrophy.评估对杜氏肌营养不良门诊患者远程实施和评分北极星动态评估的可行性和可靠性。
Children (Basel). 2022 May 16;9(5):728. doi: 10.3390/children9050728.
6
Measuring carer quality of life in Duchenne muscular dystrophy: a systematic review of the reliability and validity of self-report instruments using COSMIN.使用 COSMIN 评估杜氏肌营养不良症照护者生活质量测量工具的信度和效度的系统评价。
Health Qual Life Outcomes. 2022 Apr 2;20(1):57. doi: 10.1186/s12955-022-01964-4.
杜氏肌营养不良症和照顾者负担:系统评价。
Dev Med Child Neurol. 2018 Oct;60(10):987-996. doi: 10.1111/dmcn.13934. Epub 2018 Jun 14.
4
The experience of parents of adult sons with Duchenne muscular dystrophy regarding their prolonged roles as primary caregivers: a serial qualitative study.成年杜氏肌营养不良症儿子的父母作为主要照顾者的长期角色体验:一项连续定性研究。
Disabil Rehabil. 2019 Apr;41(7):746-752. doi: 10.1080/09638288.2017.1408148. Epub 2017 Nov 26.
5
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.杜氏肌营养不良症的负担、流行病学、成本及治疗:一项证据综述
Orphanet J Rare Dis. 2017 Apr 26;12(1):79. doi: 10.1186/s13023-017-0631-3.
6
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.欧洲杜氏肌营养不良症患者的社会/经济成本及与健康相关的生活质量
Eur J Health Econ. 2016 Apr;17 Suppl 1:19-29. doi: 10.1007/s10198-016-0782-5. Epub 2016 Apr 2.
7
Quantifying the burden of caregiving in Duchenne muscular dystrophy.量化杜氏肌营养不良症中护理的负担。
J Neurol. 2016 May;263(5):906-915. doi: 10.1007/s00415-016-8080-9. Epub 2016 Mar 10.
8
Health-related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross-sectional study.杜氏肌营养不良症患者的健康相关生活质量:一项跨国横断面研究。
Dev Med Child Neurol. 2016 May;58(5):508-15. doi: 10.1111/dmcn.12938. Epub 2015 Oct 19.
9
Subjective caregiver burden of parents of adults with Duchenne muscular dystrophy.父母对成年杜氏肌营养不良症患者的主观照顾负担。
Disabil Rehabil. 2012;34(12):988-96. doi: 10.3109/09638288.2011.628738. Epub 2011 Dec 9.
10
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.治疗 DMD 的药物和基因治疗方法的现状。
Mol Ther. 2011 May;19(5):830-40. doi: 10.1038/mt.2011.59. Epub 2011 Apr 5.